The effect of bay leaf extract (Syzygium polyanthum) on vascular endothelial growth factor (VEGF) and CD31 (PECAM-1) expression in acute coronary syndrome
Aim To investigate effect of bay leaf extract in endothelial integrity, observed by vascular endothelial growth factor (VEGF) level, VEGF and CD31 expression. Methods Thirty-two acute coronary syndrome surgery-induced Wistar Rats (Rattus novergicus) were divided into 16 bay leaf extract (treatment) groups and 16 control groups, sacrificed on day 1, 4, 7, and 14 after the induction. Serum VEGF level was determined by ELISA and expression of VEGFR-2 and CD31 were detected on immunohistochemistry. Results This study showed increased expression of serum VEGF level, and VEGFR-2 expression was found significantly on day 7 and 14 in the treatment group compared to the control group. CD31 expression was significantly different compared to the control groups on day 4, 7, and 14 of administration. Conclusion The potential effect of bay leaf extract on angiogenesis in acute coronary syndrome (ACS) as adjuvant for the treatment. Bay leaf extract has been shown to support angiogenesis and maintain endothelial integrity that leads to better prognosis for reperfusion on ischemic tissue.
Cardiovascular diseases fact sheet no. World Health Organization; 25AD. p. 317.
2.
Purnamasari D. The emergence of non-communicable disease in Indonesia. Acta Med Indones. 2019. p. 273–4.
3.
Riset kesehatan dasar 2018 (Basic health research 2018). Ministry of Health Republic of Indonesia; 25AD.
4.
Stefanadis C, Antoniou C, Tsiachris D, Pietri P. Coronary atherosclerotic vulnerable plaque: current perspectives. Am Heart J. 2017. p. 5543.
5.
Heo K, Fujiwara K, Abe J. Shear stress and atherosclerosis. Mol. 2014. p. 434–40.
6.
Ford T, Berry C, Bruyne D, Yong B, Barlis A, Fearon P, et al. Physiological predictors of acute coronary syndromes: emerging insights from the plaque to the vulnerable patient. JACC Cardiovasc Interv. 2017. p. 2539–47.
7.
Siasos G, Sara J, Zaromytidou M, Park K, Coskun A, Lerman L, et al. Local low shear stress and endothelial dysfunction in patients with nonobstructive coronary atherosclerosis. J Am Coll Cardiol. 2018. p. 2092–102.
8.
Chatzizisis Y, Coskun A, Edelman J, Feldman E, Stone C, P. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007. p. 2379–93.
9.
Chistiakov D, Orekhov A, Bobryshev Y. Effects of shear stress on endothelial cells: go with the flow. Acta Physiol. 2017. p. 382–408.
10.
Tzima E, Irani-Tehrani M, Kiosses W, Dejana E, Schultz D, Engelhardt B, et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 2005. p. 426–31.
11.
Olszewska-Pazdrak B, Hein T, Olszewska P, Carney D. Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. Am J Physiol Cell Physiol. 2009. p. 1162–70.
12.
Delisser H, Newman P, Albelda S. Platelet endothelial cell adhesion molecule (CD31). Curr Top Microbiol Immunol. 1993. p. 37.
13.
Clement M, Fornasa G, Guedj K, Mkaddem S, Gaston A, Khallou-Laschet J, et al. CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells. Proc Natl Acad Sci. 2014. p. 1101–10.
14.
Xia L, Zhang B, Sun Y, Chen B, Yu Z. Syk/PE-CAM-1 signaling pathway mediates low shear stress-induced inflammatory in atherosclerosis. 28AD.
15.
Hartanti L, Yonas S, Mustamu J, Wijaya S, Setiawan H, Soegianto L. Influence of extraction methods of bay leaves (Syzygium polyanthum) on antioxidant and HMG-CoA reductase inhibitory activity. Heliyon. 2019. p. 1485.
16.
Monsalve B, Meyer C, Palomo A, Fuentes I, E. Mechanisms of endothelial protection by natural bioactive compounds from fruit and vegetables. An Acad Bras Cienc. 2017. p. 615–33.
17.
Khurana S, Venkataraman K, Hollingsworth A, Piche M, Tai T. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients. 2013. p. 3779–827.
18.
Bassino E, Antoniotti S, Gasparri F, Munaron L. Effects of flavonoid derivatives on human microvascular endothelial cells. Nat Prod Res. 2016. p. 2831–4.
19.
Wu Y, Yin X, Wijaya C, Huang M, Mcconnell B. Acute myocardial infarction in rats. J Vis Exp. 2011. p. 2464.
20.
Lee S, Wolf P, Escudero R, Deutsch R, Jamieson S, Thistlewaite P. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med. 2000. p. 626–33.
21.
Briasoulis A, Androulakis E, Christophides T. Tousoulis D. The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure. Heart Fail Revs. 2016. p. 169–76.
22.
Ogawa H, Suefuji H, Soejima H, Nishiyama K, Misumi K, Takazoe K, et al. Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology. 2000. p. 93–9.
23.
Ramos C, Napoleão P, Selas M, Freixo C, Crespo A, Carmo M, et al. Prognostic value of VEGF in patients submitted to percutaneous coronary intervention. Dis Markers. 2014.
24.
Meier P, Gloekler S, Zbinden R, Beckh S, De Marchi S, Zbinden S. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007. p. 975–83.
25.
Flego D, Severino A, Trotta F, Previtero M, Ucci S, Zara C, et al. Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients. Basic Res Cardiol. 2014. p. 448.
26.
Zhao T, Zhao W, Chen Y, Ahokas R, Sun Y. Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc Res. 2010. p. 188–94.
27.
Yang Z, Wan J, Pan W, Zou J. Expression of vascular endothelial growth factor in cardiac repair: Signaling mechanisms mediating vascular protective effects. Int J Biol Macromol. 2018. p. 179–85.
28.
Privratsky J, Paddock C, Florey O, Newman D, Muller W, Newman P. Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci. 2011. p. 1477–85.
29.
Deutsch M, Brunner S, Grabmaier U, David R, Ott I, Huber B. Cardioprotective potential of human endothelial-colony forming cells from diabetic and nondiabetic donors. Cells. 2020. p. 588.
30.
Fang L, Wei H, Chowdhury S, Gong N, Song J, Heng C, et al. Association of Leu125Val polymorphism of platelet endothelial cell adhesion molecule-1 (PECAM-1) gene & soluble level of PECAM-1 with coronary artery disease in Asian Indians. Indian J Med Res. 2005. p. 92–9.
31.
Flego D, Severino A, Trotta F, Copponi G, Manchi M, Pedicino D, et al. Reduced CD31 expression on CD14+ CD16+ monocyte subset in acute coronary syndromes. Int J Cardiol. 2015. p. 101–4.
32.
Serebruany V, Gurbel P. Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1 (CD31) in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol. 1999. p. 153.
33.
Wilson W, Poellinger L. The dietary flavonoid quercetin modulates HIF-1n activity in endothelial cells. Biochem Biophys Res Commun. 2002. p. 446–50.
34.
Wang C, Mehendale S, Calway T, Yuan C. Botanical flavonoids on coronary heart disease. Am J Chin Med. 2011. p. 661–71.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
